ELTX – elicio therapeutics, inc. (US:NASDAQ)

News

Elicio Therapeutics Reports Inducement Grants
Elicio Therapeutics (ELTX) is now covered by LADENBURG THALM/SH SH. They set a "buy" rating and a $20.00 price target on the stock.
Elicio Therapeutics Reports Inducement Grants
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates [Yahoo! Finance]
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com